Table 3.
Variable | OS | DFS | ||||
---|---|---|---|---|---|---|
HR(95%CI) | Coef | P | HR(95%CI) | Coef | P | |
Age, y | ||||||
> 40 | Reference | Reference | ||||
≤ 40 | 2.57(1.340–4.94) | 0.945 | 0.005 | 2.53(1.43–4.47) | 0.929 | 0.001 |
Tumor location | ||||||
Outer | Reference | Reference | ||||
Inner/central | 2.24(1.416–3.54) | 0.806 | <0.001 | 1.66(1.13–2.43) | 0.505 | 0.010 |
LNM | ||||||
1 | Reference | – | – | – | ||
2 | 1.84(1.124–3.01) | 0.610 | 0.015 | |||
3 | 2.00(0.995–4.02) | 0.694 | 0.052 | |||
Stagea | ||||||
T1 | Reference | Reference | ||||
T2 | 2.02(1.225–3.34) | 0.704 | 0.006 | 1.90(1.28–2.82) | 0.641 | 0.002 |
Ki-67 | – | – | – | |||
≤ 30% | Reference | |||||
>30% | 1.74(1.089–2.80) | 0.557 | 0.021 |
Abbreviations HR: Hazard ratio; CI: confidence interval; LNM: lymph node metastasis
aOnly including T stage